Candidates identified from the initial screen ( miR-@-@p , miR-@ , miR-@b , miR-@ and miR-@a ) were validated in a further cohort of @ patients at baseline ( ~ @ days post-ACS ) and at @ and @ months post-ACS , and compared with @ controls .